Silicon Valley start-up One Health says it's too soon to publish data, but many of its canine clients are living longer than would be expected using traditional treatment.
Sen. Ron Wyden, D-Ore., has stopped short of threatening to issue a subpoena to the drugmakers, indicating that participation at the hearing isn't entirely voluntary.
The impact of the tariffs on Louisiana's economy are "acute and recognizable, given the size of the state's economy and the types of industries we're talking about," says Stephen Barnes, director of the LSU Economics & Policy Research Group.
The partial government shutdown, now in its fifth week, threatens to delay Food and Drug Administration approval of potentially lifesaving drugs and treatments.
BioMarin's clinical trial of a gene therapy for hemophilia is providing hope to patients with the disease. It is an experimental treatment that uses a virus to deliver a healthy copy of a gene to make up for one that causes excessive bleeding.
Genentech's Xofluza, baloxavir marboxil, is meant to treat acute uncomplicated influenza in patients 12 years and older who have had symptoms for no more than 48 hours.
Allergies are on the rise and researchers are trying new methods to help combat potentially life threatening reactions.
SpaceX shows off its Crew Dragon capsule and introduces the first four NASA astronauts who will fly in it.
New diet-based approaches to diabetes prevention and treatment include fresh-food prescriptions and ketogenic diets rather than drugs alone. Spending on drugs reached $53 billion last year, with mixed results.
Competition, market conditions and shrinking sales of milk are having a big impact on farmers like the Coombs family.